http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013544259-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401
filingDate 2011-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2013-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2013544259-A
titleOfInvention Pharmaceutical dosage form
abstract A pH responsive and mucoadhesive pharmaceutical dosage form for release of a pharmaceutically active agent is described. This dosage form includes a mucoadhesive layer for site-specific mucoadhesion, a water-insoluble outer layer, and an intermediate layer comprising one or more pharmaceutically active agents for site-specific delivery. Different membrane layers serve different functions to create a drug delivery system that can deliver a drug to a specific site for a specific time period and a specific drug release pattern. The dosage form can have two or more intermediate layers, each layer containing an active agent. The mucoadhesive layer can also contain an active agent. The dosage form is preferably an oral or buccal delivery form for release of the active agent into the gastrointestinal tract. The intermediate layer can be an electrospun fiber membrane layer containing an active agent.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7126260-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020083800-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7353980-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020241685-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022224464-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020506307-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019504075-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7040418-B2
priorityDate 2010-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003521493-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010002418-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP28713
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5478883
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9N2D4
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00792
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11489
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493149
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559351
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GMY8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497074
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555582
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533932
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27822
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GMY6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32051
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24846132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44093
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GMY7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410534446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3100
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517445
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4091
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451799018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506968
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP28712
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81497

Total number of triples: 87.